💡 How to fairly assess #radiotherapy #innovations? The new #VBRO paper proposes a framework categorising them as: 🔹Drug-centred 🔹Radiation-centred 🔹Radiation-enabling 🔹Operational 👉 Published in the Green Journal: bit.ly/4qIoaj5

🟢 ESTRO recommendations on preoperative radiation therapy in #breastcancer, just published in the Green Journal. Endorsed by @astro-org.bsky.social. 👉 bit.ly/4qIdgtE #radiotherapy #recommendations #GreenJournal #radonc

Boost your chest cancer imaging skills! Join the course on 24–25 Nov, for expert-led cases, interactive sessions & latest trends. 💻 Register: buff.ly/7EuB1bB #Radiology #Oncology #ChestImaging #LungCancer

📢Upcoming ESTRO webinar supported by IBA: 12 Nov, 16:00–17:30 CET Prof. Steven J. Frank presents the first Phase III IMPT vs IMRT trial for oropharyngeal cancer, moderated by Jon Cacicedo Fernandez de Bobadilla. ℹ️ More info: bit.ly/47QQJmU 🔗 Register now (free & open to all): bit.ly/4hKkBoE #ESTRO

📢 Join us in Zagreb, Croatia (or online) for the ESTRO School course: 🎯 IMRT and VMAT: Best Practices and New Trends 🗓️ 1–4 March 2026 📌 Early reg: 🏫 3 Dec 2025 | 💻 7 Jan 2026 Explore the latest in treatment planning with top experts. 🔗https://bit.ly/4hVXLdF #ESTROSchool26

⏳ It’s almost time for #ESTROGEC25! Join us in Belgrade, 19–20 Nov, for “Brachytherapy – strength through open mind.” Two days of innovation, collaboration & inspiration in image-guided brachytherapy. 👉 Register: bit.ly/3Tdcs0s #ESTROGEC25

🚨 Call for Applications: TipsRO - Technical Innovations and Patient Support in Radiation Oncology, part of the ESTRO journal family, is seeking a new Associate Editor! ⏳ Apply by: 21 November 📆 Start: January 2026 ℹ bit.ly/4qYk1I6

📢 Happening Today! Join us 17:00 CET for the webinar: “Management of SCLC in the Immunotherapy Era” 💡 Hear from global experts on RT, systemic therapies & more! 👉 Register free: bit.ly/3IWaD6z #RadiationOncology #SCLC #Immunotherapy #MedicalEducation

📣 Last call to join the STAND survey (Studying The Acceptability of Non-Supine Delivery). 📆 Deadline: 11 November. 💡 Share your views on upright #radiotherapy – treating patients in a sitting, perching, or standing position without a rotating gantry. 👉 bit.ly/42U0YnH

📢 1 week left to submit your abstract for #ESTRO26! ⏰ Deadline: 12 Nov 2025 🎯 Theme: Innovating Radiation Oncology, Together Be part of the global dialogue shaping the future of our field. Submit now 👉 bit.ly/4lxLf4o #CallForAbstracts

📊 A new #ESTROVBRO study analysed 3700+ papers on #radiotherapy innovations (2012–2022): 🔹Only 1% randomised controlled trials 🔹Mostly observational 🔹Endpoints varied widely ➡️ “One-size-fits-all” evidence doesn’t work, RT needs a tailored approach. 👉 bit.ly/4orbHPp

📢 Be part of a landmark moment in head & neck cancer care! Join this ESTRO webinar, supported by IBA Proton Therapy. 🗓 12 Nov 2025 | 16:00–17:30 CET | Online 🔗 Free & open to all: bit.ly/4hKkBoE ℹ️ More info: bit.ly/47QQJmU #HeadandNeckCancer #Radonc

🎉 That’s a wrap for the ESTRO Physics Workshop 2025 in Toulouse! 190 participants, inspiring talks & great connections across the #MedicalPhysics community.👏 Thanks to our faculty, committee & industry partners for making it a success! #ESTROPhysicsWorkshop #GoldAnchor #IBA #RadFormation #Varian

🎓 Thank you to all participants of the ESTRO course on Advanced Skills in Modern Radiotherapy! 👏 Your engagement and shared experiences made this course truly enriching. We hope you left inspired to apply new skills in your clinical practice! #ESTROSchool25

⏳ Last chance to apply for the first-ever ESTRO Clinical Workshop! Join us in Vienna, 12–13 March 2026, to explore 5 hot topics with leading experts and shape the future of clinical radiation oncology. 📅 Deadline: 4 Nov 👉 Apply now: bit.ly/49nug25 #ESTROCLIN26

Your voice matters for #radiotherapy #safety! 🙌 Complete our short survey on reporting & learning practices. Your input will help improve ROSEIS and make procedures safer for patients. 👉 bit.ly/4gLbZgO ROSEIS: #RadiationOncology Safety Education and Information System

🏆 Travel Grant Award Report – Wolfsberg 2025 ⚡ Why do some cancers resist #radiotherapy? At the #WolfsbergMeeting 2025, experts explored #Radioresistance — from metabolism & DNA repair to senescence. 👉 bit.ly/4q7KyC3 #Radiobiology #CancerResearch

📣 Join the ESTRO Biology Committee! ESTRO is looking for 2️ new members to join its Biology Committee — a dynamic team working to strengthen and promote #biology within the #radiotherapy community. 📆 Deadline: 10 December ℹ bit.ly/4ne8mS4 ✅ bit.ly/4qDD4Y7 #Radiobiology

Elderly #HeadAndNeckCancer patients are underrepresented in trials, making treatment decisions tough. ✅ Share your clinical experience (oro-/hypopharynx, larynx, oral cavity) to guide future care. 🕐~10 min | 🔒Anonymous 👉http://bit.ly/46snipr #Radiotherapy #radonc

Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 years and older with high-risk breast cancer based on the genomic grade index: a randomised phase 3 trial published in The Lancet. 👉 Read it before your patients: bit.ly/42Hvh0R

🏆 Travel Grant Award Report – Wolfsberg 2025 Can low-dose CT radiation influence #coloncancer risk? A poster at the #WolfsbergMeeting explored how effects may vary with the stage of carcinogenesis and genetic background. 👉 bit.ly/3KW8HLT #Radiobiology #Radiotherapy

🎸 The ESTRO stage is calling! Are you a musician in the ESTRO community? Join the ESTRO Factor Band at #ESTRO26 in Stockholm🇸🇪 Perform at the Opening Ceremony, the ESTRO Party & more!🎵 Solo, duo, or band — all welcome. 📅 Apply by 16 Nov 2025 🔗 bit.ly/4qf6D1D #RadOnc

Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: a phase 2 study published in Med. 👉 Read it before your patients: bit.ly/4oh9EwF

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors, published in Annals of Oncology: 👉 bit.ly/4hgBS8v

🗣️Join our ESTRO webinar on Management of SCLC in the Immunotherapy Era — discover what’s new for radiation oncologists. 🗓️ 5 Nov | 17:00–18:30 CET 🎓 With Prof Faivre-Finn & Dr Dubash 💬 Live Q&A included! 👉 Register: bit.ly/3KAbjPB #RadiationOncology #Immunotherapy

⏳ Only 2 weeks left to apply for the ESTRO Educational Travel Grants 2025! Get up to €3000 to visit an institute of excellence and bring new expertise back to your department. 📅 Deadline: 31 Oct 2025 🔗 Apply: bit.ly/4oHNhS3 #ESTROSchool25 #radiationoncology

🏆 Travel Grant Award Report #WolfsbergMeeting 2025 How does radiation-induced lung toxicity affect the gut? This award-winning poster examined the gut-lung axis, bacterial biomarkers & immune responses in preclinical models. 👉 bit.ly/4n6Spx0 #RadiationBiology #Radiotherapy

Extending the duration of endocrine treatment for early breast cancer, published in The Lancet. 👉 Read it before your patients: bit.ly/42FePOR

🚨 The #ICHNO26 searchable programme is LIVE! Explore top scientific sessions & plan your congress. 📅 19–21 Mar 2026 | ✨ Early bird rates for ESTRO members, students & more. 🔍 Prog: bit.ly/4qadFou 🔗 bit.ly/3L2CHWn #HeadAndNeckCancer

🧬 ESTRO’s #radiobiology course, held in Rome, offered a deep dive into the biology behind #radiotherapy. From stem cells to clinical cases, attendees gained practical insights, strengthened their skills, and connected with peers from around the world. 👉 bit.ly/4qaz9Bx #ESTROSchool

🏆 Travel Grant Award – #WolfsbergMeeting 2025 How can targeting #hypoxia improve #headandneckcancer treatment? An award-winning poster shows how novel compounds can overcome hypoxia-driven #radioresistance. 👉 shorturl.at/nY0WL #RadiationBiology #Radiotherapy #HNSCC

📢 The first-ever ESTRO Clinical Workshop is coming to Vienna | 12–13 Mar 2026! Spots are limited—don’t miss out. 📌 Submit your motivational statement by 22 Oct to secure your place. 💻 Apply now 👉 bit.ly/47wlj5G #ESTROCLIN26 #ClinicalWorkshop #RadiationOncology

🗣️ New #ESTROWebinar! Management of SCLC in the Immunotherapy Era 🗓 5 Nov | 17:00–18:00 CET Chaired by Prof Corinne Faivre-Finn & Dr Suraiya Dubash (UK) 💻 Live Q&A with experts! More info & Registration here: 👉 bit.ly/3KAbjPB #RadiationOncology #LungCancer #SCLC #Immunotherapy #Webinar

📣 What do you need from industry to advance #brachytherapy? Clinicians, physicists, RTTs & researchers, share your input! 📌Results will be discussed at the GEC-ESTRO Workshop 2025 (19–20 Nov, Belgrade). ⏳Deadline: 22 Oct 👉Take the survey: bit.ly/3KAbGcX #ESTROGEC25

🚨 ICHNO 2026 registrations are OPEN! Join the 10th Int’l Congress on Head & Neck Oncology "Driven by Biology, Centred on the Person" 📅 19–21 Mar 2026 | Seville, Spain Save with early bird rates! 🔗 Register now: bit.ly/3L2CHWn #ICHNO26 #Radonc

📢 We’re thrilled to launch the first-ever Clinical Workshop 🎉An interactive, hands-on experience in Vienna, 12–13 March 2026! 5 hot topics led by experts. 🗣️Chair: Maximilian Niyazi 🗓️ Apply by 22 Oct 2025 — limited places! 👉 bit.ly/4obpHw8 #ESTROCLIN26 #Clinical

📢 Attention #RTTs! Take this 5–10 min survey on incident reporting & attitudes across Europe. Your input helps improve #safety & #quality in #radiotherapy. 🔒 Anonymous 🧾 Ethically approved 📅 31 October 👉 bit.ly/3KvQRiO 📌Supported by ESTRO

Selective elimination of breast surgery for invasive breast cancer: a nonrandomized clinical trial published in JAMA Oncology. 👉 Read it before your patients: bit.ly/4ngvikv

✨The #ESTRO25 Congress Report is out! 📌Green Journal/The Lancet OncolOGY joint session 📌Award-winning papers 📌Track & technique highlights 👉 bit.ly/4nYNI9o Will your study appear in the report next year? ✅Submit your abstract by 12 Nov! #ESTRO26 bit.ly/4lxLf4o

📣 Calling #radonc, #medphys, #RTTs & researchers! ✅ Join the survey on Studying The Acceptability of Non-Supine Delivery. 💡Share your views on upright #radiotherapy – treating patients in a sitting, perching, or standing position, without a rotating gantry. 👉 bit.ly/42U0YnH

How do we define target volumes that truly impact outcomes? Over 80 participants from 23 countries joined the ESTRO #TargetVolume Determination course in Bucharest to investigate hands-on contouring, AI insights & more. 👉 bit.ly/4gyeJOq #RadiationOncology #ESTROSchool #Radiotherapy

⏰ 1 week left to submit your abstract for #ICHNO26 in Seville! 🗓 19–21 Mar 2026. Join experts shaping head & neck oncology. Deadline: 8 Oct 23:59 CET Submit today! bit.ly/44ZqSGK #HeadAndNeckOncology #ESTRO #EHNS #ESMO

📢 ESTRO Membership 2026 is OPEN! Join 10,000+ #RadOnc professionals worldwide 🌍 ✨ Access research, education & discounts 🤝 Connect with peers globally 🎓 New: Undergraduate Medical Student category 👉 bit.ly/3Why1OQ #ESTROMembership26 #JoinUsNow

📊 ~50% of nurses experience burnout, impacting both professionals and patients. 💡Read ESTRO volunteer Ludwig Van den Berghe’s testimony with research insights. 🙏Thanks, Ludwig, for sharing and raising awareness! 👉 bit.ly/4nZuCA5

Your voice matters for #radiotherapy #safety! 🙌 Complete our short survey on reporting & learning practices. Your input will help improve ROSEIS and make procedures safer for patients. 👉 bit.ly/4gLbZgO ROSEIS: #RadiationOncology Safety Education and Information System

#ProtonTherapy’s biological impact goes beyond a fixed RBE: Preclinical studies show the need to better understand LET, fractionation & toxicity to refine treatment. 👉 bit.ly/3Vktrz5 #Radiobiology #OncologyResearch #Radiotherapy

Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer, published in @TheLancetOncol. 👉 Read it before your patients: bit.ly/42C3eQm

Resistance Training and Lymphedema in Breast Cancer Survivors, published in JAMA Network Open. 👉 Read it before your patients: bit.ly/4pChF0K

📢 Med. physicists, physicians, engineers & #radiotherapy professionals: share your experience with 3D printing! Help shape an open-access paper & guide future clinical use. 🗓 Deadline: 20 Oct Partial results @ ESTRO Physics workshop! 👉 bit.ly/3KzQUda #ESTROPhys25 #medphys

Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial, published in @thelancet.com. 👉 Read it before your patients: bit.ly/466SfRi